Bangkok Lab And Cosmetic PCL (BKK:BLC)
Thailand · Delayed Price · Currency is THB 3.800
+0.020 (0.53%)
At close: Dec 4, 2025
BKK:BLC Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,680 | 1,557 | 1,406 | 1,238 | 1,087 | 1,105 |
Other Revenue | 14.56 | 21.94 | 10.99 | 3.48 | 7.94 | 1.59 |
| 1,695 | 1,579 | 1,417 | 1,242 | 1,095 | 1,107 | |
Revenue Growth (YoY) | 9.26% | 11.42% | 14.11% | 13.38% | -1.03% | - |
Cost of Revenue | 702.86 | 684.85 | 615.07 | 537.54 | 524.74 | 540.57 |
Gross Profit | 991.81 | 894.14 | 802.1 | 704.43 | 570.65 | 566.28 |
Selling, General & Admin | 742.03 | 663.61 | 601.87 | 531.57 | 481.7 | 522.63 |
Operating Expenses | 742.03 | 663.61 | 601.87 | 531.57 | 481.7 | 522.63 |
Operating Income | 249.78 | 230.53 | 200.23 | 172.87 | 88.94 | 43.64 |
Interest Expense | -7.81 | -12.38 | -25.76 | -28.34 | -28.4 | -29.03 |
Interest & Investment Income | - | - | - | - | - | 1.8 |
Currency Exchange Gain (Loss) | - | - | - | - | - | 0.2 |
EBT Excluding Unusual Items | 241.97 | 218.15 | 174.48 | 144.53 | 60.54 | 16.61 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0 |
Pretax Income | 241.97 | 218.15 | 174.48 | 144.53 | 60.54 | 16.62 |
Income Tax Expense | 50.08 | 42.06 | 23.65 | 14.85 | 9.41 | 2.88 |
Earnings From Continuing Operations | 191.89 | 176.08 | 150.82 | 129.68 | 51.13 | 13.74 |
Minority Interest in Earnings | -3.42 | -4.73 | -5.43 | -3.96 | 0.48 | 1.61 |
Net Income | 188.48 | 171.35 | 145.39 | 125.72 | 51.61 | 15.35 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 3.29 |
Net Income to Common | 188.48 | 171.35 | 145.39 | 125.72 | 51.61 | 12.06 |
Net Income Growth | 12.96% | 17.85% | 15.65% | 143.60% | 236.25% | - |
Shares Outstanding (Basic) | 600 | 600 | 544 | 447 | 364 | 271 |
Shares Outstanding (Diluted) | 600 | 600 | 544 | 447 | 364 | 271 |
Shares Change (YoY) | -0.03% | 10.21% | 21.77% | 23.00% | 34.13% | - |
EPS (Basic) | 0.31 | 0.29 | 0.27 | 0.28 | 0.14 | 0.04 |
EPS (Diluted) | 0.31 | 0.29 | 0.27 | 0.28 | 0.14 | 0.04 |
EPS Growth | 12.99% | 6.94% | -5.02% | 98.04% | 219.06% | - |
Free Cash Flow | -436.23 | 38.67 | 70.26 | 121.57 | 110.9 | 10.43 |
Free Cash Flow Per Share | -0.73 | 0.06 | 0.13 | 0.27 | 0.30 | 0.04 |
Dividend Per Share | 0.190 | 0.150 | 0.100 | - | - | - |
Dividend Growth | 46.15% | 50.00% | - | - | - | - |
Gross Margin | 58.53% | 56.63% | 56.60% | 56.72% | 52.09% | 51.16% |
Operating Margin | 14.74% | 14.60% | 14.13% | 13.92% | 8.12% | 3.94% |
Profit Margin | 11.12% | 10.85% | 10.26% | 10.12% | 4.71% | 1.09% |
Free Cash Flow Margin | -25.74% | 2.45% | 4.96% | 9.79% | 10.12% | 0.94% |
EBITDA | 292.93 | 271.11 | 235.39 | 206.2 | 121.22 | 75.45 |
EBITDA Margin | 17.29% | 17.17% | 16.61% | 16.60% | 11.07% | 6.82% |
D&A For EBITDA | 43.15 | 40.58 | 35.16 | 33.33 | 32.28 | 31.81 |
EBIT | 249.78 | 230.53 | 200.23 | 172.87 | 88.94 | 43.64 |
EBIT Margin | 14.74% | 14.60% | 14.13% | 13.92% | 8.12% | 3.94% |
Effective Tax Rate | 20.70% | 19.28% | 13.56% | 10.27% | 15.54% | 17.31% |
Revenue as Reported | 1,695 | 1,579 | 1,417 | 1,242 | 1,095 | 1,109 |
Advertising Expenses | - | - | - | - | - | 87.1 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.